Global Isothermal Nucleic Acid Amplification Technology Market Size To Worth USD 11.3 Billion By 2033 | CAGR of 10.4%

Global Isothermal Nucleic Acid Amplification Technology Market Size To Worth USD 11.3 Billion By 2033

According to a research report published by Spherical Insights & Consulting, the Global Isothermal Nucleic Acid Amplification Technology Market Size is to Grow from USD 4.2 Billion in 2023 to USD 11.3 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 10.4% during the projected period.

Browse key industry insights spread across 286 pages with 110 Market data tables and figures & charts from the report on the "Global Isothermal Nucleic Acid Amplification Technology Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments and Reagent), By Technology (NASBA, HAD, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2, and Others), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:  https://www.sphericalinsights.com/reports/isothermal-nucleic-acid-amplification-technology-market

Isothermal nucleic acid application technology (INAAT) is a laboratory technique for rapidly amplifying DNA or RNA sequences without the need for temperature cycling, as in traditional PCR. As a substitute, it maintains a constant temperature, making the process faster and more energy efficient. It is widely used in medical diagnostics to identify pathogens like viruses and bacteria. It does not require expensive equipment, unlike PCR, and can be used in resource-constrained settings such as rural clinics or in-field diagnostics. INAAT operates by employing enzymes that can copy and amplify nucleic acids indefinitely at a constant temperature, allowing for the rapid detection of even trace amounts of genetic material. INAAT tests can often be completed in under an hour. The rapid development of existing amplification technologies, as well as the introduction of new ones such as SPIA, LAMP, RPA, and SDA, is revealing new applications for INAAT products. For example, a report in the Analyst Journal in June 2022 used LAMP technology to create a device integrated with a smartphone that can quickly test for the Zika virus from a single blood drop. This development is expected to lead to increased market penetration in the near future. However, the requirement for instrumentation capable of thermal cycling and temperature control restricts the use of point-of-care applications for amplification techniques like PCR.

The reagent segment dominates the market with the highest market share of the global isothermal nucleic acid amplification technology market during the projected period.   

Based on the product, the global isothermal nucleic acid amplification technology market is divided into instruments and reagents. Among these, the reagent segment dominates the market with the highest market share of the wireless connectivity technology market during the projected period. Because of their widespread use in hospitals and primary care settings, as well as the increasing availability of polymerases with high strand displacement capacities. Also, with increased market penetration of INAAT diagnostics anticipated in the near future, the adoption of associated reagents is expected to accelerate during the forecast period.

The LAMP segment is anticipated to grow at the fastest pace during the projected timeframe.   

Based on the technology, the global isothermal nucleic acid amplification technology market is categorized into NASBA, HAD, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2, and others. Among these, the LAMP segment is anticipated to grow at the fastest pace during the projected timeframe. The technology supports a variety of detection methods, such as real-time fluorescence with intercalators, lateral flow, and agarose gel. As a result, the technique can detect a diverse set of RNA and DNA targets in human samples, including Zika virus and SARS-CoV-2. Also, the technique's popularity stems from its inhibitor tolerance, which enables it to be used with crude samples and minimally purified nucleic acids.

The infectious disease diagnostics segment is anticipated to grow at the fastest pace during the projected timeframe.   

Based on the application, the global isothermal nucleic acid amplification technology market is categorized into blood screening, infectious disease diagnostics, cancer, and others. Among these, the infectious disease diagnostics segment is anticipated to grow at the fastest pace during the projected timeframe. The recent introduction of specific INAAT kits, combined with an increase in the incidence of HIV, hepatitis A and B, and sexually transmitted diseases, is expected to drive segment growth. Growing concerns about antimicrobial resistance, as well as a greater emphasis on epidemic prevention in developing countries, are expected to drive segment growth.

North America is expected to hold the largest share of the global isothermal nucleic acid amplification technology market over the forecast period.

North America is expected to hold the largest share of the global isothermal nucleic acid amplification technology market over the forecast period. Because of North America's established research infrastructure and increased demand for nucleic acid amplification-based diagnostics for infectious disease prevention. Furthermore, a high per capita healthcare expenditure and a greater emphasis on point-of-care diagnostic methods are expected to propel market growth.

Asia Pacific is predicted to grow at the fastest pace in the global isothermal nucleic acid amplification technology market during the projected period. The rising prevalence of chronic conditions, increased market player involvement in the region, and rising R&D investments are all expected to contribute significantly to the Asia Pacific market's growth over the forecast period.

Major vendors in the global isothermal nucleic acid amplification technology market are Grifols, S.A., Hologic, Inc., Abbott Laboratories, Meridian Bioscience, Eiken Chemical Co., Ltd., BioMérieux SA, Tecan Trading AG, New England Biolabs, QIAGEN N.V., DiaSorin S.p.A., General Electric, OptiGene Limited, Quidel Corporation, Thermo Fisher Scientific, Genomtec, and Others.

Recent Developments

• In February 2023, Sherlock Biosciences announced the acquisition of Sense Biodetection in order to strengthen its position in the INAAT market.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global isothermal nucleic acid amplification technology market based on the below-mentioned segments: 

Global Isothermal Nucleic Acid Amplification Technology Market, By Product

• Instruments
• Reagent

Global Isothermal Nucleic Acid Amplification Technology Market, By Technology

• NASBA
• HAD
• LAMP
• SDA
• SPIA
• NEAR
• TMA
• RCA
• RPA
• SMAP2
• Others

Global Isothermal Nucleic Acid Amplification Technology Market, By Application

• Blood Screening
• Infectious Disease Diagnostics
• Cancer
• Others

Global Isothermal Nucleic Acid Amplification Technology Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter